Aevis Victoria - Public Comps and Valuation Multiples

Aevis Victoria Overview

About Aevis Victoria

Aevis Victoria SA is a medical care company with five segments: Hospitals, Hospitality, Real Estate, Others, and Corporate. The Hospitals business segment operates private hospitals and clinics. The Hospitality business segment owns and operates hospitals. The Real Estate segment operates healthcare-related real estate properties. The Others segment provides ambulance services, such as urgent patient transport and hospital transfers. The Corporate segment operates other miscellaneous business activities. It generates the vast majority of its revenue in Switzerland. The company expects further development in its healthcare, hospitality, and real estate businesses.

Founded

2006

HQ

Employees

n/a

Website

aevis.com

Sectors

Hospitals & Clinics

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$1.4B

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Aevis Victoria Financials

Aevis Victoria has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Aevis Victoria achieved revenue of $1.1B and an EBITDA of $60.4M.

Aevis Victoria expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Aevis Victoria valuation multiples based on analyst estimates

Aevis Victoria P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$1.2B	$1.1B	XXX	XXX	XXX
Gross Profit	$796M	$976M	XXX	XXX	XXX
Gross Margin	65%	91%	XXX	XXX	XXX
EBITDA	$176M	$60.4M	XXX	XXX	XXX
EBITDA Margin	14%	6%	XXX	XXX	XXX
Net Profit	-$4.8M	$66.5M	XXX	XXX	XXX
Net Margin	0%	6%	XXX	XXX	XXX
Net Debt	$847M	$987M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

Aevis Victoria Stock Performance

As of April 15, 2025, Aevis Victoria's stock price is CHF 13 (or $15).

Aevis Victoria has current market cap of CHF 1.1B (or $1.2B), and EV of CHF 1.2B (or $1.4B).

See Aevis Victoria trading valuation data

Aevis Victoria Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$1.4B	$1.2B	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Aevis Victoria Valuation Multiples

As of April 15, 2025, Aevis Victoria has market cap of $1.2B and EV of $1.4B.

Aevis Victoria's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Aevis Victoria's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for Aevis Victoria and 10K+ public comps

Aevis Victoria Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$1.4B	XXX	XXX	XXX
EV/Revenue	1.3x	XXX	XXX	XXX
EV/EBITDA	22.5x	XXX	XXX	XXX
P/E	-27.5x	XXX	XXX	XXX
P/E/Growth	n/a	XXX	XXX	XXX
EV/FCF	-18.2x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Aevis Victoria Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Aevis Victoria Valuation Multiples

Aevis Victoria's NTM/LTM revenue growth is n/a

Aevis Victoria's revenue per employee for the last fiscal year averaged $InfinityT, while opex per employee averaged $InfinityT for the same period.

Over next 12 months, Aevis Victoria's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate Aevis Victoria's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for Aevis Victoria and other 10K+ public comps

Aevis Victoria Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	-12%	XXX	XXX	XXX	XXX
EBITDA Margin	6%	XXX	XXX	XXX	XXX
EBITDA Growth	-66%	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	n/a	XXX	XXX	XXX	XXX
Revenue per Employee	$InfinityT	XXX	XXX	XXX	XXX
Opex per Employee	$InfinityT	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	2%	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	3%	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
Opex to Revenue	81%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry